Make Sure Your Alarm Is Set…
This early morning trade is constantly overlooked, but those who use it are retiring early!

Hi, I’m trading expert Dave Aquino and with my new guide, “How To Master The Retirement Trade”, you could be taking advantage of it as well!

The trade starts at 9:30EST…don’t be late!

Get a copy here!

>>>
Sasha King, insider at CareDx

Sasha King Insider Information

CMO of CareDx
Sasha King brings over 10 years of diagnostics and genetic testing experience. Most recently she worked in companion diagnostics marketing at Genentech, and was a sales leader at Ariosa Diagnostics. While at Genentech, she worked on the launch of the first FDA approved cell free DNA test in oncology, the PD-L1 test launch, and the Foundation Medicine partnership. Sasha was an early member of the commercial team at Ariosa, a leader in the field of noninvasive prenatal testing (NIPT) which is now part of the Roche Group. She led the launch of their test into Asia Pacific and Canada. Sasha previously worked at Fletcher Spaght, a life science consulting and venture capital fund. Sasha received a bachelor of science in bioengineering from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.

What is Sasha King's net worth?

The estimated net worth of Sasha King is at least $1.07 million as of June 9th, 2021. Ms. King owns 47,913 shares of CareDx stock worth more than $1,073,730 as of July 4th. This net worth approximation does not reflect any other assets that Ms. King may own. Additionally, Ms. King receives a salary of $628,870.00 as CMO at CareDx. Learn More about Sasha King's net worth.

How old is Sasha King?

Ms. King is currently 36 years old. There are 6 older executives and no younger executives at CareDx. The oldest executive at CareDx is Dr. Peter Maag Ph.D., Exec. Director, who is 55 years old. Learn More on Sasha King's age.

What is Sasha King's salary?

As the CMO of CareDx, Inc, Ms. King earned a total compensation package of $1,541,104.00 in 2020. Ms. King earned a salary of $305,100.00, stock awards of $562,050.00, options awards of $310,252.00, non-equity compensation of $362,142.00, and other compensation of $1,560.00.There are 4 executives that earn more than Ms. King. The highest earning executive at CareDx is Dr. Reginald Seeto, Pres, CEO & Director, who commands a salary of $1,510,000.00 per year. Learn More on Sasha King's salary.

How do I contact Sasha King?

The corporate mailing address for Ms. King and other CareDx executives is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. CareDx can also be reached via phone at (415) 287-2300 and via email at [email protected] Learn More on Sasha King's contact information.

Has Sasha King been buying or selling shares of CareDx?

Sasha King has not been actively trading shares of CareDx during the last quarter. As far as recent transactions, 0 shares of the stock in a transaction dated Monday, July 4th. Learn More on Sasha King's trading history.

Who are CareDx's active insiders?

CareDx's insider roster includes Paul Adler (CEO), George Bickerstaff, III (Director), Ankur Dhingra (CFO), Michael Goldberg (Director), William Hagstrom (Director), Sasha King (CMO), Peter Maag (Insider), Reginald Seeto (Insider), Ralph Snyderman (Director), and Thomas Thomas (Director). Learn More on CareDx's active insiders.

Are insiders buying or selling shares of CareDx?

In the last twelve months, CareDx insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $211,700.00. In the last twelve months, insiders at the sold shares 27 times. They sold a total of 156,443 shares worth more than $8,087,835.54. The most recent insider tranaction occured on May, 11th when Director Grace Colon sold 5,179 shares worth more than $119,168.79. Insiders at CareDx own 4.6 % of the company. Learn More about insider trades at CareDx.

Information on this page was last updated on 5/11/2022.

Sasha King Insider Trading History at CareDx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2021Sell12,435$90.01$1,119,274.3547,913View SEC Filing Icon  
6/7/2021Sell8,071$90.01$726,470.7150,567View SEC Filing Icon  
1/14/2021Sell9,875$87.55$864,556.2544,264View SEC Filing Icon  
10/8/2020Sell40,775$50.62$2,064,030.5061,760View SEC Filing Icon  
6/1/2020Sell25,402$33.10$840,806.2028,334View SEC Filing Icon  
2/14/2020Sell7,390$26.01$192,213.9048,502View SEC Filing Icon  
12/9/2019Sell2,126$21.97$46,708.2248,709View SEC Filing Icon  
7/1/2019Sell9,542$35.74$341,031.0862,045View SEC Filing Icon  
6/20/2019Sell30,840$38.38$1,183,639.2072,772View SEC Filing Icon  
5/3/2019Sell1,250$29.50$36,875.0077,427View SEC Filing Icon  
4/12/2019Sell10,000$29.81$298,100.0075,137View SEC Filing Icon  
2/22/2019Sell7,500$29.03$217,725.0081,387View SEC Filing Icon  
2/15/2019Sell2,500$25.00$62,500.0076,387View SEC Filing Icon  
10/5/2018Sell11,500$24.60$282,900.0053,542View SEC Filing Icon  
8/1/2018Sell9,458$14.03$132,695.7471,792View SEC Filing Icon  
See Full Table

Sasha King Buying and Selling Activity at CareDx

This chart shows Sasha King's buying and selling at CareDx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CareDx Company Overview

CareDx logo
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $22.41
Low: $21.57
High: $22.50

50 Day Range

MA: $25.05
Low: $20.49
High: $34.07

2 Week Range

Now: $22.41
Low: $19.34
High: $92.55

Volume

55,510 shs

Average Volume

817,234 shs

Market Capitalization

$1.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!